Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer
NCT ID: NCT01097252
Last Updated: 2014-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
104 participants
INTERVENTIONAL
2002-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
NCT01561586
Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer
NCT01461772
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients
NCT00950261
Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer
NCT00916500
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
NCT05735145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
weekly cisplatin
Weekly cisplatin 40mg/m2 during radiation therapy
radiation
radiation with cisplatin 40mg/m2, 6 cycles, every week
weekly cisplatin
weekly cisplatin 40mg/m2, 6 cycles
tri-weekly cisplatin
cisplatin 75mg/m2 three cycles, every 3 weeks
radiation
radiation with cisplatin 40mg/m2, 6 cycles, every week
tri-weekly cisplatin
cisplatin 75mg/m2, 3cycles, every 3 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiation
radiation with cisplatin 40mg/m2, 6 cycles, every week
weekly cisplatin
weekly cisplatin 40mg/m2, 6 cycles
tri-weekly cisplatin
cisplatin 75mg/m2, 3cycles, every 3 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Squamous, Adenosquamous, Adeno carcinoma cell type
* International Federation of Gynecologic Oncology (FIGO) stage IIB - IVA
* Gynecologic Oncology Group (GOG) performance status 0 - 2
Exclusion Criteria
* History of other cancer
* Hypersensitivity to platinum agents
* Pregnancy
* Serious medical disease
30 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea Cancer Center Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang-Young Ryu
Chair of Cerivcal/Ovarian Cancer Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sang-Young Ryu, MD
Role: PRINCIPAL_INVESTIGATOR
Korea Institute of Radiological & Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea Institute of Radiological & Medical Sciences
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ryu SY, Lee WM, Kim K, Park SI, Kim BJ, Kim MH, Choi SC, Cho CK, Nam BH, Lee ED. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e577-81. doi: 10.1016/j.ijrobp.2011.05.002. Epub 2011 Aug 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KCCH GY 1005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.